Defining the Cardiac Fibroblast
Author:
Affiliation:
1. Department of Cell and Molecular Biology, Center for Cardiovascular Research, University of Hawaii
Publisher
Japanese Circulation Society
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://www.jstage.jst.go.jp/article/circj/80/11/80_CJ-16-1003/_pdf
Reference134 articles.
1. 1. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005; 45: 657–687.
2. 2. Haidara MA, Assiri AS, Yassin HZ, Ammar HI, Obradovic MM, Isenovic ER. Heart failure models: Traditional and novel therapy. Curr Vasc Pharmacol 2015; 13: 658–669.
3. 3. Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, Haak MC, Jongbloed MR. Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med 2013; 18: 237–244.
4. 4. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 2004; 84: 649–698.
5. 5. Van Den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: The role of myofibroblasts. Nat Rev Cardiol 2010; 7: 30–37.
Cited by 198 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Logic-based mechanistic machine learning on high-content images reveals how drugs differentially regulate cardiac fibroblasts;Proceedings of the National Academy of Sciences;2024-01-24
2. Heart-on-a-chip systems: disease modeling and drug screening applications;Lab on a Chip;2024
3. Fibroblasts under pressure: cardiac fibroblast responses to hypertension and antihypertensive therapies;American Journal of Physiology-Heart and Circulatory Physiology;2024-01-01
4. Review of the Protective Mechanism of Curcumin on Cardiovascular Disease;Drug Design, Development and Therapy;2024-01
5. CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases;Heliyon;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3